BJL
TAK icon

Brighton Jones LLC’s Takeda Pharmaceutical TAK Stock Holding History

Brighton Jones LLC’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196K Buy
12,250
+1,273
+12% +$21.1K ﹤0.01% 1256
2026
Q1 		$203K Buy
+10,977
New +$193K ﹤0.01% 1090

Other funds holding TAK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
MAP
Managed Asset Portfolios Rochester, Michigan $875M AUM 41.9% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Brighton Jones LLC's TAK Position: Q2 2026 in Review

Brighton Jones LLC increased its Takeda Pharmaceutical (TAK) stake by 12% in Q2 2026, buying an estimated $21.1K and bringing the position to 12,250 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Brighton Jones LLC first reported a position in TAK in Q1 2026 and has held it in 2 quarters since. The position peaked at $203K in Q1 2026. 237 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Brighton Jones LLC held 12,250 shares of Takeda Pharmaceutical worth $196K as of Q2 2026.
  • Brighton Jones LLC bought 1,273 Takeda Pharmaceutical shares in Q2 2026, an estimated $21.1K.
  • Takeda Pharmaceutical made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1256 holding.
  • Brighton Jones LLC first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • Brighton Jones LLC's Takeda Pharmaceutical position peaked at $203K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.